A commercial review should not end with twenty explanations and no choices. In my LinkedIn writing, I suggested three useful questions: where growth is shifting, where the customer experience is improving or breaking down, and what we should test, stop or scale. Here is a way to run the meeting around those questions.
48 hours before the review
Ask the team to nominate no more than three decisions requiring leadership attention. Each decision owner submits a one-page brief with the decision, two or three relevant measures, competing explanations, options, risks and a recommendation. Keep the full dashboard available as supporting material rather than making it the agenda.
A 60-minute meeting
Minutes 0–10: What changed? Review material changes in performance, customer experience and market context since the previous meeting. Distinguish signal from noise.
Minutes 10–25: Diagnose one important variance. Ask for at least two plausible explanations. In pharma, check market access, supply, audience mix, channel execution, competitor activity and data limitations where relevant. Do not attribute every outcome to marketing activity.
Minutes 25–45: Choose between alternatives. For each proposed action, discuss expected benefit, resource implications, risk and what will be displaced. Decide whether to test, reallocate, redesign, stop or wait deliberately.
Minutes 45–55: Record commitments. Name the decision owner, action owner, evidence required, due date and escalation needs.
Minutes 55–60: Close the loop. Read back the decisions and identify what will be checked at the next review.
Worked example: high engagement, flat outcome
Suppose digital engagement among a priority HCP segment rises while a downstream outcome remains flat. Three explanations are plausible: targeting is too broad, the content does not address a useful customer need, or the digital interaction does not inform the next field conversation. The team should not automatically fund more reach.
Option A: increase channel spend. Option B: test a better-defined segment. Option C: repair the digital-to-field handoff. Select a bounded test based on available evidence, local conditions and permitted data use. Define what result would support further investment.
The decision log
Capture six fields for every material choice: Decision question | Evidence | Alternative explanations | Chosen action and trade-off | Accountable owner | Review date and trigger. Publish the log internally after the meeting. Begin the next review by checking commitments, not by reopening every slide.
What to remove from the agenda
Routine status updates that need no leadership decision, metrics without an action implication and operational blockers that belong in a weekly execution forum. Those topics still matter; they need the right meeting.
How to judge whether the review improved
Track decisions made, commitments closed, time taken to resolve escalations and whether new evidence changed a prior assumption. Do not reward the meeting simply for having fewer slides. The objective is better decisions with appropriate challenge, not speed at any cost.
Follow the decision
Which decision is delayed, and what evidence would change it? This question connects to two other parts of the operating model:
Illustrative management format developed from my public writing on commercial analytics and operating cadence. The views I share are my own and do not represent those of my employer.
Put this into practice
A dashboard earns its place when it changes a choice.
Use the Commercial Decision Brief to connect a signal to an owner, decision threshold and review date.
Open the Commercial Decision Brief